Long‐term durability of antibody responses after SARS‐CoV‐2 vaccination and influencing factors-Reference-Cited by-同舟云学术

Long‐term durability of antibody responses after SARS‐CoV‐2 vaccination and influencing factors

Published:2023-01-10 Issue:4 Volume:293 Page:520-523
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Ebinger Joseph E.¹^ORCID,Joung Sandy Y.¹,Wang Minhao¹,Liu Yunxian¹,Prostko John C.²,Frias Edwin C.²,Stewart James L.²,Braun Jonathan³,McGovern Dermot P. B.³,Melmed Gil Y.³,Jordan Stanley C.⁴,Claggett Brian L.⁵,Sobhani Kimia⁶,Cheng Susan¹

Affiliation:

1. Department of Cardiology Smidt Heart Institute Cedars‐Sinai Medical Center Los Angeles California USA

2. Applied Research and Technology Abbott Diagnostics Lake Forest Illinois USA

3. Inflammatory Bowel and Immunobiology Research Institute Karsh Division of Digestive and Liver Diseases Department of Medicine Cedars‐Sinai Medical Center Los Angeles California USA

4. Comprehensive Transplant Center Department of Medicine Division of Nephrology Cedars‐Sinai Medical Center Los Angeles California USA

5. Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA

6. Department of Pathology and Laboratory Medicine Cedars‐Sinai Medical Center Los Angeles California USA

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13601

Reference10 articles.

1. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

2. Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection

3. Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following Prior Infection or Vaccination;The Journal of Infectious Diseases;2024-05-08

2. Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS‐CoV‐2 infections in solid organ transplant recipients;Transplant Infectious Disease;2023-10-27

3. Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk;Nature Communications;2023-09-12

4. Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipient;Frontiers in Immunology;2023-07-03